World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
133
Citations
72200
World Ranking
210
National Ranking
136

Medicine

D-Index
134
Citations
72850
World Ranking
2134
National Ranking
1204

Research.com Recognitions

  • 2013 - Society Citation Award, Infectious Diseases Society of America

Overview

Myron S. Cohen is affiliated with the University of North Carolina at Chapel Hill in the United States. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with significant contributions in the subfields of Infectious Diseases, Virology, Epidemiology, General Health Professions, and Immunology.

The scientist's research topics focus extensively on HIV/AIDS, including:

  • HIV/AIDS Research and Interventions
  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • SARS-CoV-2 and COVID-19 Research
  • HIV, Drug Use, Sexual Risk
  • COVID-19 Clinical Research Studies
  • Adolescent Sexual and Reproductive Health

Among their recent papers are:

  • "Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women," 2021, New England Journal of Medicine
  • "Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition," 2021, New England Journal of Medicine
  • "Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial," 2022, The Lancet
  • "Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19," 2021, New England Journal of Medicine
  • "SARS-CoV-2 Variants in Patients with Immunosuppression," 2021, New England Journal of Medicine

The scientist has collaborated frequently with other researchers including:

  • Lawrence Corey
  • Deborah Donnell
  • Joseph J. Eron
  • Peter B. Gilbert
  • Susan H. Eshleman

The primary publication venues for their work include:

  • UNC Libraries
  • bioRxiv (Cold Spring Harbor Laboratory)
  • New England Journal of Medicine
  • The Journal of Infectious Diseases
  • JAIDS Journal of Acquired Immune Deficiency Syndromes

In 2013, Myron S. Cohen was recognized with the Society Citation Award from the Infectious Diseases Society of America.

Best Publications

  • Prevention of HIV-1 Infection with Early Antiretroviral Therapy

    Myron S. Cohen;Ying Q. Chen;Marybeth McCauley;Theresa Gamble

  • Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

    Brandon F. Keele;Elena E. Giorgi;Elena E. Giorgi;Jesus F. Salazar-Gonzalez;Julie M. Decker

  • Antiretroviral Therapy for the Prevention of HIV-1 Transmission

    Myron S. Cohen;Ying Q. Chen;Marybeth McCauley;Theresa Gamble

  • Sexual transmission of HIV

    Rachel A. Royce;Arlene Seña;Willard Cates;Willard Cates;Myron S. Cohen

  • Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus

    Hua-Xin Liao;Rebecca Lynch;Tongqing Zhou;Feng Gao;Feng Gao

  • Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1

    Myron S Cohen;Irving F Hoffman;Rachel A Royce;Peter Kazembe

  • The role of sexually transmitted diseases in HIV transmission

    Shannon R. Galvin;Myron S. Cohen

  • Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection.

    Jesus F. Salazar-Gonzalez;Maria G. Salazar;Brandon F. Keele;Gerald H. Learn

  • Brief but efficient: acute HIV infection and the sexual transmission of HIV.

    Christopher D. Pilcher;Hsiao Chuan Tien;Joseph J. Eron;Pietro L. Vernazza

  • Acute HIV-1 Infection

    Myron S. Cohen;George M. Shaw;Andrew J. McMichael;Barton F. Haynes

  • Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia

    Georgia D. Tomaras;Nicole L. Yates;Pinghuang Liu;Li Qin

  • Structure and immune recognition of trimeric pre-fusion HIV-1 Env

    Marie Pancera;Tongqing Zhou;Aliaksandr Druz;Ivelin S. Georgiev

  • The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection

    Nilu Goonetilleke;Michael K.P. Liu;Jesus F. Salazar-Gonzalez;Guido Ferrari

  • Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

    Raphael J Landovitz;Deborah Donnell;Meredith E Clement;Brett Hanscom

  • Prevalence of chlamydial and gonococcal infections among young adults in the United States.

    William C. Miller;Carol A. Ford;Martina Morris;Mark S. Handcock

  • Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis

    Myron S Cohen

  • Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial

    Beatriz Grinsztejn;Mina C. Hosseinipour;Heather J. Ribaudo;Susan Swindells

  • Free radicals and phagocytic cells

    Gerald M. Rosen;Sovitj Pou;Carroll L. Ramos;Myron S. Cohen

  • Mechanism of the luminol-dependent chemiluminescence of human neutrophils.

    L R DeChatelet;G D Long;P S Shirley;D A Bass

  • Syphilis in China: results of a national surveillance programme

    Zhi Qiang Chen;Guo Cheng Zhang;Xiang Dong Gong;Charles Lin;Charles Lin

Frequent Co-Authors

Irving F. Hoffman
Irving F. Hoffman University of North Carolina at Chapel Hill
William C. Miller
William C. Miller The Ohio State University
Joseph J. Eron
Joseph J. Eron University of North Carolina at Chapel Hill
Susan A. Fiscus
Susan A. Fiscus University of North Carolina at Chapel Hill
Barton F. Haynes
Barton F. Haynes Duke University
Angela D. M. Kashuba
Angela D. M. Kashuba University of North Carolina at Chapel Hill
Joseph D. Tucker
Joseph D. Tucker University of North Carolina at Chapel Hill
Bette T. Korber
Bette T. Korber Los Alamos National Laboratory
David C. Montefiori
David C. Montefiori Duke University
Susan H. Eshleman
Susan H. Eshleman Johns Hopkins University School of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Immunology opens doors to diverse healthcare careers, many of which can be enhanced through specialized nursing programs. For those looking to enter the nursing field quickly, exploring the easiest accelerated nursing programs offers a streamlined path to becoming a Bachelor of Science in Nursing (BSN) professional.

If you prefer an entry point with shorter training, consider the fastest and easiest LPN programs. These programs provide essential nursing skills in a condensed timeframe, perfect for supporting immunology-related healthcare roles.

Advanced practice nurses can build on foundational knowledge through the easiest fnp program, which prepares students to become Family Nurse Practitioners. These practitioners frequently work alongside immunologists in clinical settings.

For those interested in the mental health aspects of immunology, the top psychiatric mental health nurse practitioner programs online offer excellent clinical placements, integrating mental health care with immunological knowledge.

Best Scientists Citing Myron S. Cohen

Trending Scientists